Cargando…

A comparison of various aggregation functions in multi-criteria decision analysis for drug benefit–risk assessment

Multi-criteria decision analysis is a quantitative approach to the drug benefit–risk assessment which allows for consistent comparisons by summarising all benefits and risks in a single score. The multi-criteria decision analysis consists of several components, one of which is the utility (or loss)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menzies, Tom, Saint-Hilary, Gaelle, Mozgunov, Pavel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612697/ https://www.ncbi.nlm.nih.gov/pubmed/35044274 http://dx.doi.org/10.1177/09622802211072512

Ejemplares similares

A novel measure of drug benefit–risk assessment based on Scale Loss Score
por: Saint-Hilary, Gaelle, et al.
Publicado: (2018)

Multi-Criteria Decision Analysis for Assessment and Appraisal of Orphan Drugs
por: Iskrov, Georgi, et al.
Publicado: (2016)

Quantitative Benefit–Risk Assessment of COVID-19 Vaccines Using the Multi-Criteria Decision Analysis
por: Son, Kyung-Hwa, et al.
Publicado: (2022)

Multi-Criteria Decision Analysis for Benefit-Risk Analysis by National Regulatory Authorities
por: Chisholm, Orin, et al.
Publicado: (2022)

Assessing the Preferences for Criteria in Multi-Criteria Decision Analysis in Treatments for Rare Diseases
por: Schey, Carina, et al.
Publicado: (2020)

A comparison of representations for discrete multi-criteria decision problems()
por: Gettinger, Johannes, et al.
Publicado: (2013)

An order restricted multi‐arm multi‐stage clinical trial design
por: Serra, Alessandra, et al.
Publicado: (2022)

Interval-valued fermatean fuzzy sets with multi-criteria weighted aggregated sum product assessment-based decision analysis framework
por: Rani, Pratibha, et al.
Publicado: (2022)

Amniotic fluid polarization of fluorescence and lecithin/sphingomyelin ratio decision criteria assessed.
por: Bernstein, L. H., et al.
Publicado: (1995)

Market access of orphan drugs and the role of multi-criteria decision making
por: Simoens, Steven
Publicado: (2012)

Non-monetary valuation using Multi-Criteria Decision Analysis: Sensitivity of additive aggregation methods to scaling and compensation assumptions
por: Martin, D.M., et al.
Publicado: (2018)

Stakeholder involvement in Multi-Criteria Decision Analysis
por: Thokala, Praveen, et al.
Publicado: (2018)

Multi-criteria decision analysis for integrated water quality assessment and management support
por: Schuwirth, Nele, et al.
Publicado: (2018)

A multi-criteria decision model for assessing health and self-care ability
por: Milavec Kapun, Marija, et al.
Publicado: (2022)

Systematic assessment of benefits and risks: study protocol for a multi-criteria decision analysis using the Analytic Hierarchy Process for comparative effectiveness research
por: Maruthur, Nisa M, et al.
Publicado: (2013)

Improving Hospital Based Medical Procurement Decisions with Health Technology Assessment and Multi-Criteria Decision Analysis
por: Yang, Chai, et al.
Publicado: (2021)

Revealed preferences towards the appraisal of orphan drugs in Poland - multi criteria decision analysis
por: Kolasa, Katarzyna, et al.
Publicado: (2018)

The New Zealand drug harms ranking study: A multi-criteria decision analysis
por: Crossin, Rose, et al.
Publicado: (2023)

Integrating multi-criteria decision-making with hybrid deep learning for sentiment analysis in recommender systems
por: Angamuthu, Swathi, et al.
Publicado: (2023)

Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA)
por: Wahlster, Philip, et al.
Publicado: (2015)

Patient decision aid based on multi-criteria decision analysis for disease-modifying drugs for multiple sclerosis: prototype development
por: Kremer, I. E. H., et al.
Publicado: (2021)

Complex T-spherical fuzzy Dombi aggregation operators and their applications in multiple-criteria decision-making
por: Karaaslan, Faruk, et al.
Publicado: (2021)

Multi-criteria decision analysis (MCDA): testing a proposed MCDA framework for orphan drugs
por: Schey, C., et al.
Publicado: (2017)

Net Clinical Benefit of Oral Anticoagulants: A Multiple Criteria Decision Analysis
por: Hsu, Jason C., et al.
Publicado: (2015)

The decision‐making process and criteria in selecting candidate drugs for progeria clinical trials
por: Gordon, Leslie B, et al.
Publicado: (2016)

Various myosteatosis selection criteria and their value in the assessment of short- and long-term outcomes following liver transplantation
por: Meister, Franziska Alexandra, et al.
Publicado: (2021)

A multi-criteria decision analysis approach to assessing malaria risk in northern South America
por: Alimi, Temitope O., et al.
Publicado: (2016)

Multi Criteria Decision Making for the Multi-Satellite Image Acquisition Scheduling Problem
por: Vasegaard, Alex Elkjær, et al.
Publicado: (2020)

Multi-criteria decision making methods a comparative study
por: Triantaphyllou, Evangelos
Publicado: (2000)

Multi-criteria decision analysis via ratio and difference judgement
por: Lootsma, Freerk
Publicado: (1999)

Fuzzy multi-criteria decision-making using neutrosophic sets
por: Kahraman, Cengiz, et al.
Publicado: (2018)

Multi-criteria decision analysis: of politics, policy entrepreneurs, and processes
por: Fan, Victoria Y.
Publicado: (2018)

Financial performance evaluation by multi-criteria decision-making techniques
por: Türegün, Nida
Publicado: (2022)

Comprehensive value assessment of drugs using a multi-criteria decision analysis: An example of targeted therapies for metastatic colorectal cancer treatment
por: Hsu, Jason C., et al.
Publicado: (2019)

Criteria for assessing high-priority drug-drug interactions for clinical decision support in electronic health records
por: Phansalkar, Shobha, et al.
Publicado: (2013)

Decision Under Ignorance: A Comparison of Existing Criteria
por: Krug, Zoé, et al.
Publicado: (2020)

Evaluating the Benefits of New Drugs in Health Technology Assessment Using Multiple Criteria Decision Analysis: A Case Study on Metastatic Prostate Cancer With the Dental and Pharmaceuticals Benefits Agency (TLV) in Sweden
por: Angelis, Aris
Publicado: (2018)

Fermatean hesitant fuzzy rough aggregation operators and their applications in multiple criteria group decision-making
por: Attaullah, et al.
Publicado: (2023)

Criteria and Scoring Functions Used in Multi-criteria Decision Analysis and Value Frameworks for the Assessment of Rare Disease Therapies: A Systematic Literature Review
por: Zelei, Tamás, et al.
Publicado: (2021)

Toward an Improved Multi-Criteria Drug Harm Assessment Process and Evidence-Based Drug Policies
por: Dubljević, Veljko
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uda4j2higm410m2fnhr6i9bf9b